These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 735467)

  • 21. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Urinary tumor marker for urothelial cancer].
    Ohtani M; Iwasaki A; Shiraiwa H
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1933-7. PubMed ID: 11729491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoembryonic antigen and urological carcinoma. A review after 7 years.
    Hall RR
    Br J Urol; 1980 Apr; 52(2):166. PubMed ID: 7426968
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
    Ladusch M; Schäffner H; Ullmann L; Littmann M; Reimann S; Gindl P; Ambrosius H
    Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
    Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
    Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage migration inhibition factor test in breast tumors.
    Gutman H; Kott I; Rabinerson D; Reiss R
    Isr J Med Sci; 1986 Nov; 22(11):812-6. PubMed ID: 3793437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic approach to cancer.
    Mitchison NA
    Transplant Proc; 1970 Mar; 2(1):92-103. PubMed ID: 4107297
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immune reactivity in colorectal cancer--clinical value from a surgical viewpoint].
    Muhrer KH; Schwemmle K; Filler D; Kahle M
    Chirurg; 1982 Feb; 53(2):112-6. PubMed ID: 7075339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antigenic fractions of Hymenolepis diminuta; their usefulness in immunological examinations.
    Choromański L
    Wiad Parazytol; 1980; 26(6):571-80. PubMed ID: 6797131
    [No Abstract]   [Full Text] [Related]  

  • 31. [The EM-test a highly sensitive malignoma test].
    Tautz C; Laier E; Schneider W
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):456-8. PubMed ID: 69263
    [No Abstract]   [Full Text] [Related]  

  • 32. Feasibility of imprint cytology for evaluation of mediastinal lymph nodes in lung cancer.
    Orki A; Tezel C; Kosar A; Ersev AA; Dudu C; Arman B
    Jpn J Clin Oncol; 2006 Feb; 36(2):76-9. PubMed ID: 16436461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukocyte adherence inhibition. The detection of cellular responsiveness and serum 'blocking' factors in malignancy.
    Ablin RJ
    Allergol Immunopathol (Madr); 1975; 3(5):357-66. PubMed ID: 1227281
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
    Nakamura S
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The LMI test in colon, breast and lung cancer long survivors.
    Fazio M; Calabrese F; Coluccia C; Giacomasso S; Casadio C; Mancuso M; Negri L; Mastromatteo V
    Panminerva Med; 1992; 34(2):60-4. PubMed ID: 1408329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Penicillin shock with negative skin test and positive leukocyte migration inhibition test].
    Janicka G; Pampuch K
    Pol Tyg Lek; 1976 Oct; 31(42):1795-7. PubMed ID: 995713
    [No Abstract]   [Full Text] [Related]  

  • 37. Indirect macrophage migration inhibition response to 3-M KCl extract of gastric carcinoma.
    Akiyoshi T; Koba F; Kawaguchi M; Miyazaki S; Tsuji H
    J Natl Cancer Inst; 1982 Aug; 69(2):345-7. PubMed ID: 6955541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adenocarcinoma of the urachus with cyst formation (author's transl)].
    Bannermann C; Wagner W
    Urologe A; 1981 Nov; 20(6):392-3. PubMed ID: 7198324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Leukocyte migration inhibitory factor and basophil degranulation in drug reactions].
    Rangel H; Montero P; Espinosa F; Castillo FJ
    Rev Alerg; 1991; 38(4):105-9. PubMed ID: 1724705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of immune processes on the growth and regression of malignant tumors].
    Russo V; Russo L
    Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.